GPX4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.892200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.562400E-01
Normal-vs-Stage2
8.651400E-01
Normal-vs-Stage3
8.980200E-01
Normal-vs-Stage4
4.620400E-01
Stage1-vs-Stage2
8.971600E-01
Stage1-vs-Stage3
8.484800E-01
Stage1-vs-Stage4
4.804200E-01
Stage2-vs-Stage3
6.879000E-01
Stage2-vs-Stage4
3.584000E-02
Stage3-vs-Stage4
7.106400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.035200E-01
Normal-vs-AfricanAmerican
6.512200E-01
Normal-vs-Asian
4.423600E-01
Caucasian-vs-AfricanAmerican
3.409200E-01
Caucasian-vs-Asian
1.069390E-01
AfricanAmerican-vs-Asian
1.501370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.640600E-01
Normal-vs-Female
8.310000E-01
Male-vs-Female
6.374600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.012200E-01
Normal-vs-Age(41-60Yrs)
6.743200E-01
Normal-vs-Age(61-80Yrs)
8.949800E-01
Normal-vs-Age(81-100Yrs)
4.378800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.552600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.113400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.969400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.860600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.357600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.107000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.269000E-01
Normal-vs-Daily Drinker
4.790600E-01
Normal-vs-Weekly Drinker
5.567200E-01
Normal-vs-Occasional Drinker
4.853200E-01
Normal-vs-Social Drinker
9.418400E-01
Non Drinker-vs-Daily Drinker
6.391900E-02
Non Drinker-vs-Weekly Drinker
1.441020E-01
Non Drinker-vs-Occasional Drinker
8.950500E-02
Non Drinker-vs-Social Drinker
7.456800E-01
Daily Drinker-vs-Weekly Drinker
6.798800E-01
Daily Drinker-vs-Occasional Drinker
9.728400E-01
Daily Drinker-vs-Social Drinker
2.053200E-01
Weekly Drinker-vs-Occasional Drinker
6.714600E-01
Weekly Drinker-vs-Social Drinker
3.755800E-01
Occasional Drinker-vs-Social Drinker
2.169000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.991600E-01
Normal-vs-Grade 2
8.394600E-01
Normal-vs-Grade 3
4.932600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.327000E-01
Grade 1-vs-Grade 3
8.732800E-01
Grade 1-vs-Grade 4
5.991600E-01
Grade 2-vs-Grade 3
4.364600E-01
Grade 2-vs-Grade 4
8.394600E-01
Grade 3-vs-Grade 4
4.932600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.290600E-01
Normal-vs-NonDiabetic
6.557800E-01
Diabetic-vs-NonDiabetic
9.804800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.662000E-01
Normal-vs-NoPancreatitis
7.603000E-01
Pancreatitis-vs-NoPancreatitis
4.999600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.962400E-01
Normal-vs-N1
9.536200E-01
N0-vs-N1
7.496000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.535400E-01
Normal-vs-TP53-NonMutant
4.274000E-01
TP53-Mutant-vs-TP53-NonMutant
3.624000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
